Jianerkang Medical Co.,Ltd. (SHA:603205)
China flag China · Delayed Price · Currency is CNY
20.63
-0.13 (-0.63%)
At close: Nov 17, 2026

Jianerkang Medical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,0991,0241,0461,0341,093782.04
Revenue Growth
11.20%-2.04%1.18%-5.46%39.79%-51.83%
Gross Profit
271.03242.62233.37230.92258.43181.97
Operating Income
147.09118.25120.64126.18142.36100.98
Net Income
123.45111.44120.22123.55157.34131.63
Earnings Per Share
0.790.710.971.051.341.13
EPS Growth
17.30%-26.80%-7.95%-21.64%19.54%-69.53%

Revenue by Geography

Fiscal Year
FY 2025
Period EndingDec '25
China
114.16
Overseas
910.23
Total
1,024

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
776.99764.91721.81226.24178.2597.8
Total Debt
17.9721.76--30.0450.05
Net Cash (Debt)
759.02743.15721.81226.24148.2147.75
Net Cash Growth
6.21%2.96%219.05%52.65%210.40%89.99%
Net Cash Per Share
4.854.735.821.931.270.41

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
187.28158.79141.1157.8163.0170.6
Capital Expenditures
-100.51-69.98-39.75-84.18-66.32-48.64
Free Cash Flow
86.7788.81101.3573.6296.721.96
Free Cash Flow Growth
8.32%-12.38%37.66%-23.86%340.34%-94.07%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
24.66%23.69%22.32%22.34%23.64%23.27%
Operating Margin
13.38%11.54%11.54%12.21%13.02%12.91%
Pretax Margin
12.83%12.34%13.17%13.80%16.27%19.13%
Profit Margin
11.23%10.88%11.50%11.95%14.39%16.83%
FCF Margin
7.90%8.67%9.69%7.12%8.85%2.81%

Dividends

Fiscal Year
CurrentFY 2025FY 2024
Period EndingNov '26 Dec '25 Dec '24
Dividend Per Share
0.2500.2500.351
Dividend Per Share Growth
0%-28.78%-
Dividend Yield
1.21%0.87%1.19%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
26.1340.0238.21---
P/FCF Ratio
37.0950.2245.32---
PS Ratio
2.934.354.39---